Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Carcinoma. Found 25 abstracts

paginate
Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM. Update on perioperative systemic therapy for urothelial carcinoma. Clinical advances in hematology & oncology : H&O. 2019 Mar;17(3):176-83.
Bartel MJ, Puri R, Brahmbhatt B, Chen WC, Kim D, Simons-Linares CR, Stauffer JA, Buchanan MA, Bowers SP, Woodward TA, Wallace MB, Raimondo M, Asbun HJ. Endoscopic and surgical management of nonampullary duodenal neoplasms. Surgical endoscopy. 2018 Jun;32(6):2859-69.
Aggarwal C, Borghaei H. Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design. The oncologist. 2017 Apr 13;22(6):700-8.   PMCID: PMC5469580
Zibelman M, Plimack ER. Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm. Oncology (Williston Park). 2016 Feb;30(2):160-2, 176.
Zou ZW, Ma C, Medoro L, Chen L, Wang B, Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, Zhang WJ, Li PD. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget. 2016 Sep 20;7(38):61741-54.   PMCID: PMC5308687
Camacho-Rivera M, Ragin C, Roach V, Kalwar T, Taioli E. Breast cancer clinical characteristics and outcomes in Trinidad and Tobago. Journal of immigrant and minority health. 2015 Jun;17(3):765-72.
Haggerty AF, Mantia-Smaldone G, Siegelman E, Livolsi V, Tanyi J. Surgical diagnosis of stage I fallopian tube cancer in anti-Yo antibody paraneoplastic cerebellar degeneration. J Obstet Gynaecol. 2015 Jan;35(1):100-1.
Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, Radice P, Ramus SJ, Domchek SM, Nathanson KL, Lee A, Healey S, Nussbaum RL, Rebbeck TR, Arun BK, James P, Karlan BY, Lester J, Cass I, Terry MB, Daly MB, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Steele L, v OH, Ejlertsen B, Gerdes AM, Nielsen FC, Dennis J, Cunningham J, Hart S, Slager S, Osorio A, Benitez J, Duran M, Weitzel JN, Tafur I, Hander M, Peterlongo P, Manoukian S, Peissel B, Roversi G, Scuvera G, Bonanni B, Mariani P, Volorio S, Dolcetti R, Varesco L, Papi L, Tibiletti MG, Giannini G, Fostira F, Konstantopoulou I, Garber J, Hamann U, Donaldson A, Brewer C, Foo C, Evans DG, Frost D, Eccles D, Douglas F, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Ong KR, Walker L, Izatt L, Side LE, Kennedy MJ, Rogers MT, Porteous ME, Morrison PJ, Platte R, Eeles R, Davidson R, Hodgson S, Ellis S, Godwin AK, Rhiem K, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher D, Sutter C, Steinemann D, Bogdanova-Markov N, Kast K, Varon-Mateeva R, Wang-Gohrke S, Gehrig A, Markiefka B, Buecher B, Lefol C, Stoppa-Lyonnet D, Rouleau E, Prieur F, Damiola F, Barjhoux L, Faivre L, Longy M, Sevenet N, Sinilnikova OM, Mazoyer S, Bonadona V, Caux-Moncoutier V, Isaacs C, Van Maerken T, Claes K, Piedmonte M, Andrews L, Hays J, Rodriguez GC, Caldes T, de la Hoya M, Khan S, Hogervorst FB, Aalfs CM, de Lange JL, Meijers-Heijboer HE, van der Hout AH, Wijnen JT, van Roozendaal KE, Mensenkamp AR, van den Ouweland AM, van Deurzen CH, van der Luijt RB, Olah E, Diez O, Lazaro C, Blanco I, Teule A, Menendez M, Jakubowska A, Lubinski J, Cybulski C, Gronwald J, Jaworska-Bieniek K, Durda K, Arason A, Maugard C, Soucy P, Montagna M, Agata S, Teixeira MR, Olswold C, Lindor N, Pankratz VS, Hallberg E, Wang X, Szabo CI, Vijai J, Jacobs L, Corines M, Lincoln A, Berger A, Fink-Retter A, Singer CF, Rappaport C, Kaulich DG, Pfeiler G, Tea MK, Phelan CM, Mai PL, Greene MH, Rennert G, Imyanitov EN, Glendon G, Toland AE, Bojesen A, Pedersen IS, Jensen UB, Caligo MA, Friedman E, Berger R, Laitman Y, Rantala J, Arver B, Loman N, Borg A, Ehrencrona H, Olopade OI, Simard J, Easton DF, Chenevix-Trench G, Offit K, Couch FJ, Antoniou AC. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2014 Jan;16(6):3416.   PMCID: PMC4406179
Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2014 Jan;39(2):185-9.   PMCID: No NIH funding
Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Med Dosim. 2014 Jan;39(2):185-9.
Simhan J, Canter D, Teper E, Smaldone MC, Patil N, Patchefsky A, Guttmann MC, Milestone B, Wong YN, Hicks LA, Uzzo RG, Kutikov A. Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout study. Urology. 2012 Feb;79(2):e19-20.   PMCID: not NIH funded
Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score. European Urology. 2011 Aug;60(2):241-8.   PMCID: PMC3124570
Plimack ER, Hudes GR. Selecting Targeted Therapies for Patients With Renal Cell Carcinoma. Journal of the National Comprehensive Cancer Network. 2011 Sep;9(9):997-1007.   PMCID: not NIH funded
Balaburski GM, Dardes RC, Johnson M, Haddad B, Zhu F, Ross EA, Sengupta S, Klein-Szanto A, Liu H, Lee ES, Kim H, Jordan VC. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance. Int J Oncol. 2010 Aug;37(2):387-98.   PMCID: PMC3023309
Miller SM, Roussi P, Daly MB, Scarpato J. New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res. 2010 Nov;16(21):5094-106.   PMCID: Pmc3107031
Henske EP. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatric Nephrology. 2005 Jul;20(7):854-7.
Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL. Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate. J Urol. 2003 Jun;169(6):2160-5.
Schilder RJ, Brady MF, Spriggs D, Shea T. Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study. Gynecol Oncol. 2003 Jan;88(1):3-8.
Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun. 2003 Apr 18;303(4):1169-78.
Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 2003 Jun 15;63(12):3403-12.
Bookman MA. Developmental chemotherapy in advanced ovarian cancer: incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2001 Jan;11 Suppl 1:42-51.
Meropol NJ, Niedzwiecki D, Hollis D, Schilsky RL, Mayer RJ. Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. Cancer. 2001 Apr;91(7):1256-63.
Algan O, Pinover WH, Hanlon AL, Al-Saleem TI, Hanks GE. Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?. Radiat Oncol Investig. 1999 Jan;7(2):106-10.
Knudson AG. Hereditary predisposition to cancer. Ann N Y Acad Sci. 1997 Dec 29;833:58-67.
Martin VR, Comis RL. Small cell carcinoma of the lung: an "updated" overview. Seminars in Oncology Nursing. 1996 Nov;12(4):295-303.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Carcinoma

Carcinoma Female pathology Adult Human Middle Aged metabolism Aged genetics therapy Ovarian Neoplasms surgery drug therapy radiotherapy Young Adult Breast Neoplasms 80 and over Aged therapeutic use Male US Gov't Support-PHS physiology adverse effects antagonists & inhibitors Antineoplastic Combined Chemotherapy Protocols Disease Progression Middle Age blood Non-US Gov't Support drug effects mortality Cell Proliferation Risk Factors Mice Neoplasm Staging pharmacology diagnosis Vascular Endothelial Growth Factor A co [Complications] blood supply trends Follow-Up Studies Mutation Disease-Free Survival Adenoma biosynthesis Neoplasms Neoplastic Gene Expression Regulation methods Modified Radical Mastectomy administration & dosage Lymphokines Signal Transduction Alleles Prostate-Specific Antigen Thoracic Wall Local Neoplasm Recurrence Genetic Predisposition to Disease Dosimetry th [Therapy] Antineoplastic Agents immunology Prognosis Pathologic Neovascularization Vascular Endothelial Growth Factors Endothelial Growth Factors Treatment Outcome Radiotherapy et [Etiology] Imrt Oral Administration Progesterone Receptors carcinoma Estrogen Receptors Carboplatin Urothelium Prostatic Neoplasms Combined Modality Therapy Drug Dose-Response Relationship Paclitaxel Neoplasm RNA Intensity-Modulated Radiotherapy utilization Breast cancer Intercellular Signaling Peptides and Proteins Radiation Dosage Environment Estrogens Antisense Oligonucleotides LncRNA Peripheral Blood Stem Cell Transplantation me [Metabolism] Nerve Tissue Proteins analogs & Paraneoplastic Cerebellar Degeneration analogs & derivatives Choice Behavior Selective Estrogen Receptor Modulators Glucose Nasopharyngeal Neoplasms Neoadjuvant Therapy Survival Analysis Food and Drug Administration drug approval laparoscopic partial nephrectomy Nonampullary duodenal neoplasms Reporter Genes Base Sequence Gene Therapy Surgical resection Fatal Outcome Digestive System Endoscopy Luminescent Proteins Glycolysis Estrogen Antagonists Differential Diagnosis Comparative Study Multivariate Analysis glucose metabolism Drug Administration Schedule Neoplastic Stem Cells Cisplatin Adrenal Cortex Neoplasms Surrogate endpoint Puberty Recombinant Fusion Proteins Leucovorin Oxidoreductases Chromosome Mapping Lobular Carcinoma Nucleic Acid Synthesis Inhibitors Messenger RNA Antineoplastic agents Multigene Family Topotecan Molecular Cloning education Inbred C57BL Mice rt [Radiotherapy] Melphalan Raloxifene Hydrochloride Membrane Glycoproteins phase-iii trial Lung Neoplasms Hormonal Antineoplastic Agents interferon-alpha X-Ray Computed Tomography mTOR pathway Up-Regulation Urologic Neoplasms complications Nephrometry
Last updated on Friday, January 03, 2020